Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Bucher et al's meta-analysis of the treatment of stable angina
with percutaneous transluminal coronary angioplasty or medical
treatment is based on a small number of trials with methodological
flaws.
1 2
The conclusions could have considerable adverse
effects on the provision of revascularisation services, and we wish to
draw attention to problems with the meta-analysis. Its results should
not be used to guide clinical practice or decision making in public health.
Sievers et al recruited asymptomatic patients to randomisation between angioplasty and medical treatment.3 The atorvastatin versus revascularisation treatment (AVERT) study recruited patients who were asymptomatic or had only minimal symptoms, many of whom had only moderate coronary lesions.4 The medicine, angioplasty, or surgery study (MASS) recruited only patients with angina and a severe, very proximal, stenosis of the left anterior descending artery, who were randomised to surgery, angioplasty, or medical treatment, with an improvement in outcome after surgery.5
It